IMSEQ--a fast and error aware approach to immunogenetic sequence analysis

doi:10.1093/bioinformatics/btv309

. 2015 Sep 15;31(18):2963-71.

doi: 10.1093/bioinformatics/btv309. Epub 2015 May 18.

IMSEQ--a fast and error aware approach to immunogenetic sequence analysis

Leon Kuchenbecker¹, Mikalai Nienen², Jochen Hecht³, Avidan U Neumann³, Nina Babel³, Knut Reinert³, Peter N Robinson⁴

Affiliations

¹ Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.
² Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.
³ Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.
⁴ Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.

PMID: 25987567
DOI: 10.1093/bioinformatics/btv309

IMSEQ--a fast and error aware approach to immunogenetic sequence analysis

Leon Kuchenbecker et al. Bioinformatics. 2015.

. 2015 Sep 15;31(18):2963-71.

doi: 10.1093/bioinformatics/btv309. Epub 2015 May 18.

Authors

Leon Kuchenbecker¹, Mikalai Nienen², Jochen Hecht³, Avidan U Neumann³, Nina Babel³, Knut Reinert³, Peter N Robinson⁴

Affiliations

¹ Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.
² Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.
³ Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.
⁴ Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Department of Computer Science, Freie Universität, Berlin, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany, Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel, Marien Hospital Herne, Ruhr University Bochum, Bochum and Institute of Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.

PMID: 25987567
DOI: 10.1093/bioinformatics/btv309

Abstract

Motivation: Recombined T- and B-cell receptor repertoires are increasingly being studied using next generation sequencing (NGS) in order to interrogate the repertoire composition as well as changes in the distribution of receptor clones under different physiological and disease states. This type of analysis requires efficient and unambiguous clonotype assignment to a large number of NGS read sequences, including the identification of the incorporated V and J gene segments and the CDR3 sequence. Current tools have deficits with respect to performance, accuracy and documentation of their underlying algorithms and usage.

Results: We present IMSEQ, a method to derive clonotype repertoires from NGS data with sophisticated routines for handling errors stemming from PCR and sequencing artefacts. The application can handle different kinds of input data originating from single- or paired-end sequencing in different configurations and is generic regarding the species and gene of interest. We have carefully evaluated our method with simulated and real world data and show that IMSEQ is superior to other tools with respect to its clonotyping as well as standalone error correction and runtime performance.

Availability and implementation: IMSEQ was implemented in C++ using the SeqAn library for efficient sequence analysis. It is freely available under the GPLv2 open source license and can be downloaded at www.imtools.org.

Supplementary information: Supplementary data are available at Bioinformatics online.

Contact: lkuchenb@inf.fu-berlin.de or peter.robinson@charite.de.

PubMed Disclaimer

Cited by

Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation.
Obermayer B, Keilholz L, Conrad T, Frentsch M, Blau IW, Vuong L, Lesch S, Movasshagi K, Tietze-Stolley C, Loyal L, Henze L, Penack O, Stervbo U, Babel N, Haas S, Beule D, Bullinger L, Wittenbecher F, Na IK. Obermayer B, et al. Front Immunol. 2023 Feb 10;14:1114368. doi: 10.3389/fimmu.2023.1114368. eCollection 2023. Front Immunol. 2023. PMID: 36860867 Free PMC article.
The Role of Pre-existing Cross-Reactive Central Memory CD4 T-Cells in Vaccination With Previously Unseen Influenza Strains.
Nienen M, Stervbo U, Mölder F, Kaliszczyk S, Kuchenbecker L, Gayova L, Schweiger B, Jürchott K, Hecht J, Neumann AU, Rahmann S, Westhoff T, Reinke P, Thiel A, Babel N. Nienen M, et al. Front Immunol. 2019 Apr 4;10:593. doi: 10.3389/fimmu.2019.00593. eCollection 2019. Front Immunol. 2019. PMID: 31019503 Free PMC article.
Molecular T-Cell Repertoire Analysis as Source of Prognostic and Predictive Biomarkers for Checkpoint Blockade Immunotherapy.
Aversa I, Malanga D, Fiume G, Palmieri C. Aversa I, et al. Int J Mol Sci. 2020 Mar 30;21(7):2378. doi: 10.3390/ijms21072378. Int J Mol Sci. 2020. PMID: 32235561 Free PMC article. Review.
Baseline IL-2 and the AIH score can predict the response to standard therapy in paediatric autoimmune hepatitis.
Diestelhorst J, Junge N, Jonigk D, Schlue J, Falk CS, Manns MP, Baumann U, Jaeckel E, Taubert R. Diestelhorst J, et al. Sci Rep. 2018 Jan 11;8(1):419. doi: 10.1038/s41598-017-18818-5. Sci Rep. 2018. PMID: 29323192 Free PMC article.
Overview of methodologies for T-cell receptor repertoire analysis.
Rosati E, Dowds CM, Liaskou E, Henriksen EKK, Karlsen TH, Franke A. Rosati E, et al. BMC Biotechnol. 2017 Jul 10;17(1):61. doi: 10.1186/s12896-017-0379-9. BMC Biotechnol. 2017. PMID: 28693542 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

IMSEQ--a fast and error aware approach to immunogenetic sequence analysis

Affiliations

IMSEQ--a fast and error aware approach to immunogenetic sequence analysis

Authors

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources